Chemical Structure (Oxcarbazepine 01)
Oxcarbazepine Tablet, Film Coated
Product Images NDC 51991-293
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 51991-293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Oxcarbazepine 02)
Figure 2 (Oxcarbazepine 03)
The given text provides the seizure rate and the p-value obtained from a log-rank test. The graph shows the number of days from the 1st dose to the 1st seizure for two treatment groups: Oxcarbazepine and Placebo. Therefore, it can be inferred that the provided information is related to a study on the effectiveness of Oxcarbazepine in preventing seizures.*
Figure 3 (Oxcarbazepine 04)
Figure 4 (Oxcarbazepine 05)
The text appears to be a plot or a figure showing the time to exit in days for two treatment groups - HIGH and LOW. There is also information about the p-value of the log-rank test. It is not possible to provide a more specific description without further context.*
Principal Display Panel (150 mg Bottle Label)
This is a medication that comes in the form of a film-coated tablet containing 150mg of oxcarbazepine per tablet. The dosage and full product information can be found in the insert. The tablets contain FD&C Yellow No.5 as a color additive and must be kept in a tight container, away from children. Recommended storage temperature is between 20-25°C with permitted excursions to 15-30°C. The medication should be dispensed with a medication guide to each patient. The manufacturer is LGM Pharma Solutions LLC and the distributor is Breckenridge Pharmaceutical Inc. NDC number is 51991-292-01.*
Principal Display Panel (300 mg Bottle Label)
Each film-coated tablet of oxcarbazepine contains 300mg and is distributed by Breckenridge Pharmaceutical, Inc. The tablets may contain FD&C Yellow No. 5 (tartrazine) and should be stored in a tight container between 59-86°F. More information about dosage and usage can be found in the insert provided. This medication should be kept out of reach of children. Manufactured by LGM Pharma Solutions, LLC.*
Principal Display Panel (600 mg Bottle Label)
Each tablet contains 600mg of oxcarbazepine. The dosage and complete product information can be found in the insert. It contains a color additive FDAC Yellow No. 5 (artrazine). The tablet should be stored at 20°-25°C (77°F) with excursions permitted to 15°C-30°C (56°F-86°F). Dispense in tight container (USP). Distributed by Breckenridge Pharmaceutical, Inc. Berlin, CT 06037. It should be kept out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
